Home » Topics » Regulatory » EMA

EMA
RSS

EMA recommends approval of Sanofi Pasteur pediatric vaccine

Feb. 27, 2013

EMA confirms decision on VIVUS' MAA for obesity treatment

Feb. 25, 2013

EMA grants orphan designation to BHR Pharma's investigational agent for traumatic brain injury

Feb. 14, 2013

Prolor Biotech's hGH-CTP receives orphan drug designation in Europe

Feb. 14, 2013

Pediatric indication of Ixiaro approved in Europe

Feb. 12, 2013

EMA committee begins safety review of Diane-35 and generics

Feb. 11, 2013

EMA grants accelerated assessment to trametinib application

Feb. 8, 2013

EMA approves label extension for Abilify

Feb. 6, 2013

French ANSM to suspend marketing of Diane-35 and generics for acne

Jan. 31, 2013

Prosensa's Duchenne muscular dystrophy products achieve orphan drug status

Jan. 30, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...